Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:732896rdf:typepubmed:Citationlld:pubmed
pubmed-article:732896lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:732896lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:732896lifeskim:mentionsumls-concept:C0038585lld:lifeskim
pubmed-article:732896lifeskim:mentionsumls-concept:C1549781lld:lifeskim
pubmed-article:732896pubmed:issue2lld:pubmed
pubmed-article:732896pubmed:dateCreated1979-3-24lld:pubmed
pubmed-article:732896pubmed:abstractTextThe subfractions Fa, Fb, and Fc of crude substance P (SP) preparations made from human and bovine brains were analysed for SP and the COOH-terminal octapeptide of cholecystokinin (CCK-8). The methods were specific radioimmunoassays (RIAs) for SP and CCK-8, and bioassays on isolated organs of the guinea pig: the ileum, the gallbladder and the field-stimulated vas deferens. 1. In bioassays of synthetic peptides the vas deferens reacted specifically to SP and the gallbladder to CCK-8. 2. RIAs and bioassays revealed unequivocally that most of SP-like activity was present in Fb, while Fc contained mainly CCK-8-like activity. Varying results were obtained with Fa. 3. The pharmacologically active principle of Fc is CCK-8 or a closely related peptide. Earlier results concerning the pharmacological and neurochemical properties of Fc must be ascribed to this peptide.lld:pubmed
pubmed-article:732896pubmed:languageenglld:pubmed
pubmed-article:732896pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:732896pubmed:citationSubsetIMlld:pubmed
pubmed-article:732896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:732896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:732896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:732896pubmed:statusMEDLINElld:pubmed
pubmed-article:732896pubmed:monthNovlld:pubmed
pubmed-article:732896pubmed:issn0028-1298lld:pubmed
pubmed-article:732896pubmed:authorpubmed-author:ZetlerGGlld:pubmed
pubmed-article:732896pubmed:authorpubmed-author:PowellDDlld:pubmed
pubmed-article:732896pubmed:authorpubmed-author:SkrabanekPPlld:pubmed
pubmed-article:732896pubmed:authorpubmed-author:Vanderhaeghen...lld:pubmed
pubmed-article:732896pubmed:authorpubmed-author:CannonDDlld:pubmed
pubmed-article:732896pubmed:issnTypePrintlld:pubmed
pubmed-article:732896pubmed:volume305lld:pubmed
pubmed-article:732896pubmed:ownerNLMlld:pubmed
pubmed-article:732896pubmed:authorsCompleteYlld:pubmed
pubmed-article:732896pubmed:pagination189-90lld:pubmed
pubmed-article:732896pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-A...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-C...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-G...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-P...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-B...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-C...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-C...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-M...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-S...lld:pubmed
pubmed-article:732896pubmed:meshHeadingpubmed-meshheading:732896-R...lld:pubmed
pubmed-article:732896pubmed:year1978lld:pubmed
pubmed-article:732896pubmed:articleTitleCrude substance P from brain contains a cholecystokinin-like peptide.lld:pubmed
pubmed-article:732896pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:732896pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:732896lld:pubmed